CD2AP and glioblastoma: Finally, we acquired GBM tissues and brain tissues from non-tumor patients and confirmed that CD2AP levels were significantly increased in GBM (grades IV) tissues than in non-tumor tissues and low-grade tumor tissues (I, II and III) (Fig. 1J, K).